The past is not the future in tobacco control.
Cigarette smoking prevalence
Electronic cigarettes
Harm reduction
Nicotine addiction
Product regulation
Quit ratios
Smoking cessation
Smoking initiation
Tobacco control
Journal
Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
20
02
2020
revised:
25
05
2020
accepted:
06
06
2020
pubmed:
1
7
2020
medline:
25
6
2021
entrez:
1
7
2020
Statut:
ppublish
Résumé
In this paper we have attempted to identify missed opportunities to change the trajectory of smoking and smoking caused diseases in America over the past 100 years. Many of the missed opportunities identified are due to the actions of cigarette manufacturers who misled the public about the dangers of cigarette smoking, the addictiveness of nicotine, and the feasibility of providing lower risk alternative nicotine delivery products to addicted smokers. An important lesson learned from the past is that treating all tobacco/nicotine products as equivalently harmful is counterproductive to public health as it only serves to protect the most lethal nicotine product - cigarettes. Since 2000, the evolving marketplace of lower risk nicotine products combined with regulatory authority over tobacco products represents a new opportunity to dramatically transform the cigarette business in ways that were never imagined when the war on tobacco was raging decades ago. However, this requires embracing risk-proportionate regulation, taxation policies, and providing consumers with accurate public messaging on product relative risks. A regulatory framework based on sound science that encourages and rewards new or existing manufacturers to invest in consumer acceptable lower risk products to replace cigarettes needs to be encouraged. The past is indeed not the future in smoking control, but it may be difficult to escape the past unless a realignment of market forces and policies can be achieved.
Identifiants
pubmed: 32603797
pii: S0091-7435(20)30207-3
doi: 10.1016/j.ypmed.2020.106183
pmc: PMC7680276
mid: NIHMS1607586
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
106183Subventions
Organisme : NCI NIH HHS
ID : P01 CA200512
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
N Engl J Med. 1994 Jul 14;331(2):123-5
pubmed: 7818638
MMWR Morb Mortal Wkly Rep. 2013 Feb 8;62(5):81-7
pubmed: 23388551
Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):32-6
pubmed: 24420984
N Engl J Med. 2017 Sep 21;377(12):1111-1114
pubmed: 28813211
Lancet Public Health. 2020 Apr;5(4):e180-e181
pubmed: 31981490
Nicotine Tob Res. 2020 May 26;22(6):975-983
pubmed: 31131861
N Engl J Med. 2020 Feb 20;382(8):697-705
pubmed: 31860793
Tob Control. 2006 Dec;15 Suppl 4:iv9-16
pubmed: 17130629
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
BMJ. 2019 Jun 20;365:l2219
pubmed: 31221636
Harm Reduct J. 2018 Apr 16;15(1):21
pubmed: 29661189
N Engl J Med. 2013 Jan 24;368(4):351-64
pubmed: 23343064
Br Med J. 1954 Jun 26;1(4877):1451-5
pubmed: 13160495
J Am Med Assoc. 1954 Aug 7;155(15):1316-28
pubmed: 13174399
MMWR CDC Surveill Summ. 1994 Nov 18;43(3):1-43
pubmed: 7969014
BMJ. 2004 Jan 10;328(7431):72
pubmed: 14715602
JAMA. 2014 Jan 8;311(2):164-71
pubmed: 24399555
Tob Control. 2006 Dec;15 Suppl 4:iv84-9
pubmed: 17130628
Tob Control. 2020 May 23;:
pubmed: 32447313
Cancer Res. 1953 Dec;13(12):855-64
pubmed: 13116124
CA Cancer J Clin. 2018 Jul;68(4):240-245
pubmed: 29889305
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1070-6
pubmed: 17548665
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019
pubmed: 31725711
Am J Public Health. 2006 Feb;96(2):222-32
pubmed: 16434689
Annu Rev Public Health. 2018 Apr 1;39:193-213
pubmed: 29323611
N Engl J Med. 1957 Jan 17;256(3):97-104
pubmed: 13388038
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S363-9
pubmed: 15799599
Cancer Res. 1950 Jan;10(1):49-58
pubmed: 15398042
Bull World Health Organ. 2006 Jun;84(6):494-6
pubmed: 16799735
JAMA. 2019 Dec 3;322(21):2095-2103
pubmed: 31688912
Tob Control. 2019 Nov;28(6):629-635
pubmed: 30459182
Addict Behav. 2019 Apr;91:180-187
pubmed: 30502927
N Engl J Med. 2018 May 3;378(18):1725-1733
pubmed: 29543114
N Y State J Med. 1983 Dec;83(13):1252-3
pubmed: 6582365
Tob Control. 2001;10 Suppl 1:i17-23
pubmed: 11740040
Am J Public Health. 1989 Feb;79(2):144-51
pubmed: 2913831
J Am Med Assoc. 1950 May 27;143(4):329-36
pubmed: 15415260
Tob Control. 2018 Jan;27(1):18-25
pubmed: 28970328
Nicotine Tob Res. 2005 Oct;7(5):779-89
pubmed: 16191749
Am J Public Health Nations Health. 1968 Aug;58(8):1396-403
pubmed: 5691372
Science. 2019 Dec 13;366(6471):1318-1320
pubmed: 31831661
Oncogene. 2002 Oct 21;21(48):7349-64
pubmed: 12379878
JAMA Intern Med. 2019 Dec 1;179(12):1710-1712
pubmed: 31633739
Am J Prev Med. 2013 Mar;44(3):207-15
pubmed: 23415116
J Am Med Assoc. 1950 May 27;143(4):336-8
pubmed: 15415261